Calcineurin

Other Neuronal Signaling Related Inhibitors

Secretase GluR GABA Receptor Dopamine Receptor 5-HT Receptor P2 Receptor AChR Histamine Receptor MAO Beta Amyloid

Cat.No.	Product Name	Information	Product Use Citations	Product Validations
S5003	FK506 (Tacrolimus)	Tacrolimus (FK506) is a 23-membered macrolide lactone, it reduces peptidyl-prolyl isomerase activity in T cells by binding to the immunophilin FKBP12 (FK506 binding protein) creating a new complex. Tacrolimus also inhibits the phosphatase activity of calcineurin. Tacrolimus induces vascular endothelial autophagy.	Proc Natl Acad Sci U S A, 2025, 122(4):e2418317122 J Nanobiotechnology, 2025, 23(1):32 PLoS Pathog, 2025, 21(1):e1012872
S2286	Cyclosporin A	Cyclosporin A, a non-polar cyclic oligopeptide, is an immunosuppressive agent that binds to cyclophilin and then inhibits calcineurin with IC50 of 7 nM in a cell-free assay. Cyclosporin A is generally given following transplant surgery to prevent rejection and has been used to test its toxic effect on a perfused 3D proximal tubule model.Cyclosporin A (NSC 290193) can be used to induce animal models of Chronic Rejection of Liver Transplantation.	Frontiers in Immunology, May 25, 2022, 861292 Circulation Research, March 27, 2026, e327680 Anticancer Research, March 2023, 1103-1112

Cat.No.

Product Name

Information

Product Use Citations

Product Validations

S5003

FK506 (Tacrolimus)

Tacrolimus (FK506) is a 23-membered macrolide lactone, it reduces peptidyl-prolyl isomerase activity in T cells by binding to the immunophilin FKBP12 (FK506 binding protein) creating a new complex. Tacrolimus also inhibits the phosphatase activity of calcineurin. Tacrolimus induces vascular endothelial autophagy.

Proc Natl Acad Sci U S A, 2025, 122(4):e2418317122

J Nanobiotechnology, 2025, 23(1):32

PLoS Pathog, 2025, 21(1):e1012872

Verified customer review of FK506 (Tacrolimus)

S2286

Cyclosporin A

Cyclosporin A, a non-polar cyclic oligopeptide, is an immunosuppressive agent that binds to cyclophilin and then inhibits calcineurin with IC50 of 7 nM in a cell-free assay. Cyclosporin A is generally given following transplant surgery to prevent rejection and has been used to test its toxic effect on a perfused 3D proximal tubule model.Cyclosporin A (NSC 290193) can be used to induce animal models of Chronic Rejection of Liver Transplantation.

Frontiers in Immunology, May 25, 2022, 861292

Circulation Research, March 27, 2026, e327680

Anticancer Research, March 2023, 1103-1112

Verified customer review of Cyclosporin A